Ziyond

Ziyond Pharmaceutical Co., Ltd. (referred to as "Ziyond Pharmaceutical"), as a national key "little giant" enterprise specializing in precision, innovation, and innovation, and a "chain leader" enterprise in the biopharmaceutical industry chain in Wuxi, has long been deeply involved in the field of skin health and is committed to building a core competitive advantage in the skin industry. The company has built a Loff around issues such as nasal and facial skin diseases, superficial fungal infections, onychomycosis, immune inflammatory skin diseases, pigmentary diseases, and scalp and hair diseases ®、 Liv ®、 Jinnuer ®、 Quality Run ® The product matrix covers mainstream e-commerce platforms such as Alibaba Health and JD Health, and has won honors such as "AAA level well-known trademark brand" and "2023 outstanding brand". The company has established a national CNAS laboratory, a national BSL-2 laboratory, a national postdoctoral research workstation, and multiple provincial-level research and development platforms. It has also carried out in-depth industry university research cooperation with Jiangsu Industrial Research Institute, China Pharmaceutical University, Jiangnan University, and other institutions to continuously promote the upgrading of skin topical formulation technology and explore innovative cosmetic raw materials. In the future, Ziyond Pharmaceutical will continue to deepen its dual wheel drive strategy of "technological innovation+marketing innovation", steadily promote the expansion of product layout from head to toe, the extension of category ecology from medicine to cosmetics, and the expansion of market territory from domestic to international, developing into a leader in the field of skin and safeguarding skin health!